Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 49,108 |
|
|||||
| News | - | ||||||
| Day High | 1.28 | Low High |
|||||
| Day Low | 1.24 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Personalis Inc | PSNL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.015 | 1.20% | 1.265 | 15:30:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.25 | 1.24 | 1.28 | 1.265 | 1.25 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 527 | 49,108 | US$ 1.26 | US$ 62,009 | - | 0.8906 - 2.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:13:56 | 1 | US$ 1.23 | USD |
Personalis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 64.14M | 50.50M | - | 73.48M | -108.3M | -2.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Personalis News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PSNL Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.20 | 1.4199 | 1.18 | 1.30 | 193,940 | 0.065 | 5.42% |
| 1 Month | 1.50 | 1.54 | 1.18 | 1.32 | 228,959 | -0.235 | -15.67% |
| 3 Months | 1.30 | 1.80 | 1.12 | 1.44 | 333,616 | -0.035 | -2.69% |
| 6 Months | 0.96 | 2.38 | 0.8906 | 1.47 | 511,867 | 0.305 | 31.77% |
| 1 Year | 2.22 | 2.60 | 0.8906 | 1.59 | 368,828 | -0.955 | -43.02% |
| 3 Years | 23.41 | 28.47 | 0.8906 | 7.67 | 443,099 | -22.15 | -94.60% |
| 5 Years | 23.70 | 53.46 | 0.8906 | 14.67 | 491,458 | -22.44 | -94.66% |
Personalis Description
| Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions. |
